EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perceived value of antihypertensives for dementia, heart disease, or death: a randomized experiment

Alexander Chaitoff, Ciaran Kohli-Lynch, Kenzie A Cameron, Donovan T. Maust, Kenneth M Langa, Deborah A Levine, John T Wilkins, Mercedes R. Carnethon, Alexander R Zheutlin

American Journal of Preventive Cardiology · 2026-10 · 102562

DOI: 10.1016/j.ajpc.2026.102562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-10. Verfasst von Alexander Chaitoff und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many eligible patients elect not to use antihypertensive medications. It is unclear if highlighting certain disease-specific benefits could elicit a stronger desire to take antihypertensive medication and thus offer a low-touch method to increase medication use. We tested the hypothesis that framing the benefits of antihypertensives to prevent specific pathology, such as dementia, would affect how patients value antihypertensive medication.

Methods

We conducted a randomized, web-based experiment among census-matched participants from the United States ≥50 years of age via CloudResearch Prime Panels. Participants were randomized 1:1:1:1 to one of four framing vignettes describing a clinician’s recommendation to start antihypertensive therapy emphasizing prevention of (1) dementia, (2) cardiovascular disease (CVD), (3) death, or (4) all three combined. The primary outcome was self-reported monthly willingness to pay (WTP) out-of-pocket for the medication. Secondary outcomes included WTP as a proportion of income, total perceived value, intention to discuss hypertension with a clinician, and WTP among subgroups of participants.

Results

Of the 1,023 randomized participants, 907 responses met quality metrics and were included in the final sample. Mean participant age was 63.6 (standard deviation [SD]=9.6) years; 52.1% were women. The proportion of adults willing to pay >$0 exceeded 85% in all arms. Across arms, median monthly WTP out-of-pocket was $20 (interquartile range 10–50) with no significant differences by framing (p = 0.79) or in subgroups.

Conclusion

Framing antihypertensive medication benefits around prevention of dementia, CVD, death, or their combination did not impact financial value assigned to antihypertensive treatment.

Zitieren

APA

Chaitoff, A., Kohli-Lynch, C., Cameron, K. A., Maust, D. T., Langa, K. M., Levine, D. A., Wilkins, J. T., Carnethon, M. R., & Zheutlin, A. R. (2026). Perceived value of antihypertensives for dementia, heart disease, or death: a randomized experiment. American Journal of Preventive Cardiology, 102562. https://doi.org/10.1016/j.ajpc.2026.102562

Vancouver

Chaitoff A, Kohli-Lynch C, Cameron KA, Maust DT, Langa KM, Levine DA, et al. Perceived value of antihypertensives for dementia, heart disease, or death: a randomized experiment. American Journal of Preventive Cardiology. 2026:102562. doi:10.1016/j.ajpc.2026.102562

BibTeX
@article{Chaitoff2026,
  author = {Chaitoff, Alexander and Kohli-Lynch, Ciaran and Cameron, Kenzie A and Maust, Donovan T. and Langa, Kenneth M and Levine, Deborah A and Wilkins, John T and Carnethon, Mercedes R. and Zheutlin, Alexander R},
  title = {Perceived value of antihypertensives for dementia, heart disease, or death: a randomized experiment},
  journal = {American Journal of Preventive Cardiology},
  year = {2026},
  pages = {102562},
  doi = {10.1016/j.ajpc.2026.102562}
}
Kostenlos starten →